Myoung-Ock Ahn – Keynote
Former President & CEO National Medical Center of Korea
Dr. AHN, Myoung-Ock(MD, PhD, DrPH, MPH) was the President & CEO of National Medical Center of Korea(2014-2017) and Professor of Medical School and Graduate School of Health and Welfare, CHA University(1999-2018) as well as a member of the Korean National Assembly(Parliamentarian: 2004-2008).
She is the medical doctor specialized in OB & Gyn(in Korea as well as in the USA)(subspecialty; maternal fetal medicine) and Preventive Medicine(UCLA in the U.S), who holds public health background as well(MPH & DrPH from UCLA, PhD from Yonsei University, Korea).
She was also working as the chairman of the Advisory committee to Speaker of the Korean National Assembly, Future Vision committee for the Women and Children of Korea(2012-2013) as well as founding Chairman of the Board of Directors, Women’s Human Rights Commission of Korea(2009-2013).
When she was working as a parliamentarian, she was recognized as the best parliamentarian to propose the most bills and pass the most bills in the history during one term. She used to work as a governance board member of International network of WHO-HPH(Health Promoting Hospitals & Health Services).
Until recently by the end of 2017, she had worked as a President & CEO of National Medical Center of Korea. National Medical Center of Korea is the control tower of Korea’s public health and medical services consisting of 212 public hospitals and medical disaster preparedness center. National Emergency Medical Center(NEMC) belongs to National Medical center as well. This NEMC governs and coordinates 539 hospitals equipped with emergency rooms and 40 trauma centers providing diverse services nationally.
Also she had served as a Asia Pacific Regional Committee Member of WAGGGS(World Association of Girl Guides and Girl Scouts) between 2016-2019.
Dr. Ursula Amstutz – Keynote
Research Ggroup Lader at the Institute of Clinical Chemistry & Deputy Head of the Clinical Genomics Lab at the Inselspital Bern University Hospital in Bern, Switzerland
Ursula Amstutz is a research group leader at the Institute of Clinical Chemistry and deputy head of the Clinical Genomics Lab at the Inselspital Bern University Hospital in Bern, Switzerland.
She received training in biology, population genetics and biomedical sciences at the University of Bern and in pharmacogenomics and drug safety and effectiveness research with the Canadian Pharmacogenomics Network for Drug Safety at the University of British Columbia, Canada.
In 2016, she obtained the venia docendi (habilitation) at the University of Bern, Switzerland. Her current research focuses on the genetic basis of severe adverse drug reactions and the clinical utility of cell-free DNA based minimally-invasive diagnostics in the context of solid organ transplantation and cancer treatment.
Paola Barbarino – Panel 3
CEO of ADI (Alzhaimer Disease International)
Paola is CEO of Alzheimer’s Disease International. Prior to this, she was CEO of LIFE and occupied senior positions with Cass Business School, Tate, British Library and IIED. She is a Board Member of the World Dementia Council, a Trustee of The Postal Museum and of Lauderdale House. Previously she was a Non-Executive Director of the Non-Communicable Disease Alliance (NCDA), a Trustee of Shelter, the housing/homelessness charity, and of MLA London. She holds a degree cum laude in Classics from Federico II Napoli University, an MA in Field and Analytical Techniques in Archaeology and an MA in Library and Information Science both from University College London.
Sabina Brennan, Ph.D – Panel 5
Dr Sabina Brennan is a psychologist, neuroscientist, host of the Super Brain podcast and author of the No 1 best-seller 100 Days to a Younger Brain.
Dr Brennan leads Brain Fit, a study of brain health, lifestyle, genomics and dementia.
Her mission to promote brain health, through quirky animations, talks and online resources, has won her awards for science communication and recognition of the societal impact of her work.
Dr Brennan is a passionate advocate and volunteers on multiple committees and panels.
She has advised both the Irish and UK governments on matters related to ageing, brain health and dementia and is the Irish national representative on the Medical and Scientific Advisory Panel for Alzheimer’s Disease International.
Her new book Beating Brain Fog (Orion Spring) will be published 4th March 2021.
Andy Bushell, Ph.D – Panel 6
BSC, PhD, EMBA
For 35 years I have worked in R&D of new medicines. I live to find ways to avoid preventable disease in society and build equitable access to medicines.
In 2012 I founded the Chronic Disease Foundation in South Africa, empowering Community Health workers using mobile technologies.
I saw heavy burden of NCDs when they can develop without effective health surveillance systems. Inspired to change this I began work with WHO Be Healthy Be Mobile, contributed to the WISH policy maker guidance on diabetes in 2013, did my Executive MBA at INSEAD in 2017 and co-founded a non-profit association OoNiDa in 2018 so we could drive the changes needed in global health systems.
I contributed to the Broadband Commission white paper on Digital Health systems in 2019, and in a delegation to the government of Chile in late 2019.
Franka Cadée – Panel 2
President of the International Confederation of Midwives
Franka Cadée is serving her second term as the President of the International Confederation of Midwives (2017-2023).
She is an expert on Midwifery and consultant on sexual and reproductive healthcare with over 30 years of strategy and policy developments, advocacy, leadership, research and project management. With her anthropological and midwifery background, Franka has lived and worked across a range of differently resourced countries and is well aware of the realities of midwifery practice in various cultural contexts.
She is a strong proponent of a human rights based approach to healthcare in general and midwifery in particular.
Franka is known to many for her PhD research work on twinning collaborations between associations of midwives and manages several cross cultural twinning projects for the Royal Dutch Organization of Midwives (KNOV).
Previously, she served on the ICM Board as treasurer (2002-2008) and on the ICM Council as a KNOV Delegate (2008 -2017).
Dr. Neerja Chowdhary – Panel 2 & 5
Technical Officer, Brain Health Unit – Department of Mental Health and Substance Use
World Health Organization (WHO), Switzerland
Dr Neerja Chowdhary is a technical officer in the Department of Mental Health and Substance Use In WHO headquarters. A psychiatrist by training, she works in the Brain Health team.
Her role includes supporting implementation of the Global action plan on the public health response to dementia 2017-2025.
She led the development of the WHO dementia risk reduction guidelines. She is also the focal point for WHO’s maternal mental health work.
Meryl Comer – Panel 1
Co-Founder & Chair Global Alliance on Women’s Brain Health Co-Founder, UsAgainstAlzheimers
Meryl Comer is a founding partner and chair of The Global Alliance on Women’s Brain Health and a co-founder of UsAgainstAlzheimers. For more than a decade (2007-2019), Ms Comer served as President and CEO of the Geoffrey Beene Foundation Alzheimer’s Initiative, a catalyst funder, targeting AD prevention through spirited public engagement campaigns, early assessment technologies, support of the first “virtual registry”, champion of AD patient and caregivers, and pre-clincial AD research to modify disease risk. She serves on the NIH National Advisory Council on Aging (NACA).
In 2012, she led the formation of the 21st Century BrainTrust® (21CBT), a non-profit partnership to advance mobile health technologies and brain health. Comer is also co-principal investigator for the PCORI Alzheimer’s Patient/Caregiver Research Network in partnership with the Mayo Clinic, UCSF’s Brain Health Registry, and USAgainstAlzheimer’s Networks. In 2009, she served on the bi-partisan Alzheimer’s Study Group, charged with presenting a National Strategic Plan to Congress.
An Emmy-award winning reporter, veteran TV producer and business talk show host, Meryl Comer was one of the first women in the early 1980’s to host a nationally syndicated TV debate show to specialize in business news as it relates to public policy.
Comer’s New York Times bestseller, Slow Dancing with a Stranger (HarperCollins ) released in 2014), offered an unflinching account of the couple’s 22-year battle with her husband’s early onset Alzheimer’s disease as a much-needed wake-up call for an honest dialogue about this fatal neurodegenerative disease. One hundred percent of proceeds from Slow Dancing with a Stranger (HarperCollins) supports Alzheimer’s research.
Frédéric Destrebecq – Panel 4
Executive Director of the European Brain Council
Frédéric Destrebecq is the Executive Director of the European Brain Council since October 2014. In this capacity, he is responsible for providing strategic direction and leadership while managing the day to day operations of EBC and its ongoing relationships with its member associations and other stakeholders, as well as representing the organisation in various European and national forums.
Prior to this position, Fred served the European Union of Medical Specialists (UEMS) as Chief Executive Officer, and previously as Director for European Affairs. Fred holds a Master Degree in Political Science and International Relations from the Université Catholique de Louvain (Belgium).
He also studied at the Institut d’Etudes Politiques (Paris) and University of Wales College (Cardiff), in the framework of the former EU Socrates exchange programme.
Lukas Engelberger – Opening
Health Councilor city of Basel
Since 2014, Dr. iur., LLM, Lukas Engelberger is a member of the Government of the Canton Basel-Stadt and Head of the Public Health Department.
He is President of the executive committee of the Swiss Conference of the Cantonal Ministers of Public Health (GDK) and Member of the Board of Swissmedic (Swiss Agency for Therapeutic Products). He also is Member of the Board of Cantosana AG.
Before his election to the government, Mr. Engelberger was working as legal counsel for a global pharmaceutical company headquatered in Basel.
Rickard Forsman – Panel 6
CEO, Geras Solutions
Rickard is CEO of Geras Solutions based in Stockholm, Sweden. Geras Solutions help individuals with Alzheimer’s’ and other cognitive diseases, and they support healthcare to help patients get the care they deserve. This is done by digitalizing parts of the diagnostic process for cognitive assessment using AI and smart devices. Geras Solutions is also providing methods that help individuals lower risk of cognitive impairment by working with lifestyle changes.
Rickard holds a MSc degree in Mechanical Engineering and Business Design as well as a BSc in Economics. Rickard has several years experience from Management Consulting with EY working in both Healthcare and Pharma, mainly in Germany, Switzerland and Sweden. He has also worked for Novartis Pharma AG in Basel focusing on innovative digital solutions.
Kathryn Goetzke – Panel 1
Chief Mood Officer, The Mood Factory
Kathryn created an award winning program, Hopeful Minds, teaching hope to kids free globally, a known protective factor for anxiety and depression.
She is author of The Biggest Little Book About Hope, launched her own brand, Mood-scents, and teaches how to create more hope and happiness in the workplace and life. Hope and happiness are proven methods for improving engagement, productivity, safety, performance, and sales, and both are measurable. And what we can measure, we can improve.
Robbert Harms – Panel 6
Scientific Data Analists, Altoida
Before joining Altoida, Robbert Harms funded his study with his own software company, graduated with honors in operations research and finished a PhD in neuroscience.
The open-source brain analysis software he developed during his PhD is now used globally and in multiple ivy-league universities. During his PhD he was part-time employed as a data analyst for the IMAGEMEND (Imaging Genetics for Mental Disorders) consortium, solving hard problems using big data.
He now works for Altoida as a machine learning expert. In this role he continuously works on improving Altoida’s machine learning models, regularly speaks at conferences and collaborates in scientific writing. His greatest passion is providing business solutions using his skills in mathematics and software engineering.
Raj Long – Panel 3
Regulatory Development & Access Strategy Expert
Deputy Director, Integrated Development– Bill & Melinda Gates Foundation, London, UK
Raj is a senior executive with over 20 years of experience in drug development. Raj brings a unique strategic expertise blending private heath and public heath sectors including having worked with regulators in the US, EU, Asia, Africa and South America. She is currently a Deputy Director at the Bill & Melinda Gates Foundation (BMGF) regulatory, safety surveillance strengthening and gene drive in vectors.
Previously, she was the Global Head of Regulatory GEHC UK, Head of Regulatory International AGL in Novartis, Switzerland and Vice-President, Regulatory International at Bristol-Myers Squibb, USA.
Additionally, Raj served as an expert reviewer in multiple platforms including UK Innovative Medicines and Medtech Review Advisory Group, EU Horizon 2020 Expert Register, advisory secondment in WHO on Access and 2 year assignment on the dementia challenge to the Department of Health, England.
She was also a member and Vice-Chair of the World Dementia Council. Raj also continues to support in an advisory capacity in multiple regulatory and access roles in Africa, India and other regions internationally.
Louise Howard – Panel 2
Professor of Women’s Mental Health at KCL
Professor Louise Howard is Professor of Women’s Mental Health at KCL and Honorary Perinatal Psychiatrist at the South London and Maudsley NHS Foundation Trust.
She received funding from the National Institute for Health Research and charitable foundations to carry out research into perinatal mental health, she received a prestigious NIHR Professorship in maternal mental health 2013-18 and is now an NIHR Senior Investigator.
She chaired the NICE Guideline on Antenatal and Postnatal Mental Health and edited a Lancet series on perinatal mental health in 2014. She is president-elect of the International Marce Society, a perinatal mental health society for academics and practitioners in www.marcesociety.com.
She also leads a UK Research and Innovation funded Network on Violence, Abuse and Mental Health.
Lynne Hughes, Ph.D – Panel 3
VP and Head of Medical CNS Strategy at IQVIA
Lynne Hughes has worked in clinical research for more than 34 years and has lived and worked during this time period in both the US and in Europe.
She has recently retired from IQVIA where she worked for almost 24 years and her last role there as was Vice President and Global Head of CNS Medical Strategy.
Lynne has worked exclusively in neurology while at IQVIA and has managed global development programs both from the operational perspective as a program director and also from the design perspective – working with many clients on their clinical development plan for their product.
She has provided consultancy advice in Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, acute care, neuro-orphan diseases, epilepsy and pain, and was involved in a number of investment opportunities within IQVIA. In particular, she was on a number of advisory boards, with particular interest in neurocognitive assessment and design of appropriate studies to assess neurocognitive dysfunction. She was a member of a number of steering and / or executive committees for global neurology clients and had responsibility for several consultancy programs for investment opportunities within all areas of neurology.
Lynne sits on the G7 World Dementia Council and on the EPAD consortium for AD and is a member of the NIA- NIH task force for recruitment into AD trials. She is also a member of the Leadership team for DAVOS and co-chairs one of the 3 working groups within DAVOS : Global Clinical Trials.
In addition, she is a member of the ATRI/Gates AD initiative and is currently active in this role to look at the bottlenecks in global AD clinical trials and how to address these.
Her last role at IQVIA was in developing evidence-based strategies for the most efficient conduct of clinical trials / programs for IQVIA’s global neurology clients and she provided consolidated scientific, therapeutic and operational input and support for clients drug development, from a clinical trial development plan to a stand- alone trial. She has been involved, to varying extents, in the development of every neurology product on the market today.
She is PMP certified and has been since 2000 and this certification is up to date.
Mara Hank Moret – BBP Campaign Switzerland
WBP Honorary President
Mara Hank Moret is an angel investor/philanthropist, Vice-Chair of the Global BBP BrainTrust, and Honorary President of the Women’s Brain Project- Switzerland.
Her charitable work extends internationally and has included Laureus Sport for Good Foundation based in the UK and Por Ayudar in Mexico, dedicated to helping the disadvantage improve their quality of life.
Previously she worked for the Tourism Board at the Mexican Embassy in London and for the Commerce Department at the US Embassies in London and Paris.
Born in Tijuana, Mexico, and educated in the United States, Ms. Moret holds two Bachelor of Arts degrees, one in Political Science and the other in Sociology from the University of San Diego, California, USA.
In recent years, she has chosen to focus on her role as mother of three children, ages 12, 10, and 7, in their most formative years.
Her philanthropic work has continued on a personal basis and on behalf of Lobnek Wealth Management.
She lives with her husband and children in Geneva, Switzerland.
Elena Moro, M.D., Ph.D – Panel 3
Director of the Movement Disorders Unit, CHU Grenoble, University Grenoble-Alpes, Grenoble; Board Member EAN
Dr. Elena Moro graduated in Medicine at the University of Trieste (Italy) in 1989 and completed her residency in Neurology at the Catholic University in Rome (Italy) in 1996.
She received her PhD in Neurosciences from the Catholic University in Rome. She did her fellowship in surgery for movement disorders in Grenoble, France, under the supervision of Dr. P. Pollak and Dr. AL Benabid. In 2002, she joined the Division of Neurology at the University of Toronto (Canada) as medical Director of the surgical program for Movement Disorders at the Toronto Western Hospital.
In 2012, she moved to Grenoble, France, as Professor of Neurology at the Grenoble Alpes University (CHU Grenoble). She is currently the Director of the Movement Disorders Center in Grenoble, and the Head of the Department of Psychiatry, Neurology, Neurological Rehabilitation and Forensic Medicine.
She is also responsible of the international relationship of the Faculty of Medicine.
She has been actively involved in academic research, and in international academic societies, like the International Movement Disorders Society (being member of the European Section Executive Board), the European Academy of Neurology (EAN, just been elected as Secretary General).
She is the co-Chair of the EAN Task Force about gender and diversity issues in neurology. Her major area of interest is surgical treatment of movement disorders, especially deep brain stimulation.
Lisa Mosconi, Ph.D – Panel 5
Associate Professor of Neuroscience in Neurology and Radiology at Weill Cornell Medical College (WCMC)
Dr. Lisa Mosconi, PhD, is Associate Professor of Neuroscience in Neurology and Radiology at Weill Cornell Medical College (WCMC), where she serves as Director of the Women’s Brain Initiative (WBI) research program and Associate Director of the Alzheimer’s Prevention Clinic.
She also is an adjunct faculty member at the Department of Psychiatry at NYU School of Medicine. Dr. Mosconi is well known for her research on the early detection of Alzheimer’s disease in at-risk individuals, women in particular, using brain imaging techniques such as PET and MRI.
Clare O’Dea – Panel 2
Author and Journalist
Originally from Ireland, Clare’s work as a journalist spans three countries and more than two decades. She is the author of The Naked Swiss: A Nation Behind 10 Myths, published by Bergli Books in 2018, and described by the Dublin Review of Books as “innovative” and “unafraid”.
Clare’s second book, The Naked Irish: Portrait of a Nation Beyond the Clichés (Red Stag Books, 2019), also challenges national stereotypes, drawing on history, culture, politics, economics, reportage and personal experience. Clare is based in Switzerland, on the invisible line where the French- and German-speaking cultures meet. A former Irish Times journalist, she spent 10 years working for www.swissinfo.ch and currently contributes to their science coverage.
Jennifer Payne – Panel 2
Director, Women’s Mood Disorders Center, Johns Hopkins School of Medicine, USA
Dr. Payne received her B.S. in biology at Davidson College in Davidson, NC and her M.D. from Washington University Medical School in St. Louis, MO.
She completed her residency in psychiatry at the Johns Hopkins Hospital where she served as chief resident during her last year.
Dr. Payne then completed a fellowship in mood disorders through the Mood and Anxiety Disorders Program at the NIMH.
Dr. Payne joined the Johns Hopkins faculty in 2003 and was promoted to Associate Professor in 2011.
Dr. Payne is the founder and Director of the Women’s Mood Disorders Center and, in addition to providing outstanding clinical care for women with mood disorders, conducts research into the genetic, biological, and environmental factors involved in postpartum depression.
She and her colleagues have recently identified two epigenetic biomarkers of postpartum depression and are working hard to replicate this work with NIH funding.
Dr. Payne also serves as the Deputy Representative of the Women’s Caucus to the American Psychiatric Association Assembly, has been named a Distinguished Fellow by the American Psychiatric Association, and served on the Maryland State Perinatal Mental Health Task Force resulting in state legislation improving resources available for perinatal women and their doctors.
Most recently she was appointed to the American Psychiatric Association’s Committee on Women’s Mental Health and is serving as President Elect for both the Marcé of North America (MONA) and the International Marcé Perinatal Mental Health Societies.
Sofia Petersson – Panel 3
Patient diagnosed with early-onset Alzheimer’s and WBP Ambassador
I am a woman of 44 years, who has been impacted by Alzheimer’s Disease for more than half of my life. My grandmother was buried during my first year and the autopsy showed Alzheimer’s.
When I was 14 my father was affected by the disease and eventually died in 1999. His seven years younger brother died seven years after in the same disease.
I am thus committed to educate people about the Alzheimer’s Disease. With money from the Swedish Alzheimer Association I was able together with two other persons to make a film about being young and related to this disease.
I could not have imagined that seventeen years after my father’s death, I would receive the news that I was affected as well! l At the age of 39.
Unfortunately, I had to struggle at first to believed by doctors. When I passed most of the standardized tests, the doctors said that it was nothing to be worried about. I had to change doctors twice! But I finally got the help, when I got in contact with my father’s old retired doctor… While the medical investigation was going on, I studied to be a health educator and managed a three-year education at the university.
My goal is to write about the many challenges of young-onset Alzheimer’s patients, and especially women’s encounters.
Read my stories @ “Sofia’s Corner“.
Maurizio Pompili – Panel 1
M.D., Ph.D. Full Professor and Chair of Psychiatry, Faculty of Medicine and Psychology
Maurizio Pompili, M.D, Ph.D. is Full Professor and Chair of Psychiatry as part of the Faculty of Medicine and Psychology at Sapienza University of Rome, Italy, where he received his M.D. degree, where he trained in Psychiatry (both summa cum laude).
He is the Director of the Residency Training Program in Psychiatry of his faculty, and He is the Director of the University Psychiatric Clinic and the Director of the Suicide Prevention Center at Sant’Andrea Hospital in Rome.
He is the President of the Psychiatric Rehabilitation Technique degree program at the Sapienza University of Rome.
He has a doctoral degree in Experimental and Clinical Neurosciences. He was also part of the Community at McLean Hospital – Harvard Medical School, the USA, where he received a fellowship in psychiatry.
He is the recipient of the American Association of Suicidology’s 2008 Shneidman Award for “Outstanding contributions in research in suicidology.”
Apart from being the Italian Representative of the International Association for Suicide Prevention (IASP) for eight years, he has been afterward one of the Vice-Presidents of this association. He is now Co-Chair of the IASP Special Interest Group in Risk Resilience and Reasons for Living. He is also a member of the International Academy for Suicide Research and the American Association of Suicidology. He is also President of the Suicidology Section of the Italian Psychiatric Society.
He has published more than 400 papers on suicide, bipolar disorders and other psychiatric perspectives, including original research articles, book chapters, and editorials. He co-edited ten international books on suicide
He ranks in the top 10 suicide authors of 500 world suicide authors listed in the ISI Web of Science (this is in terms of the number of focused works on the topic of suicide that are indexed in the ISI Web of Science).
He has been recognized by Expertscape as an expert in suicide, ranking 1st worldwide. H-index: 51 (July 2020).
Patricia Pozo-Rosich, MD Ph.D – Panel 4
Headache and Craniofacial Pain Clinical Unit at the University Hospital Vall d’Hebron in Barcelona
Patricia Pozo-Rosich MD PhD, is a specialist in Neurology.
She is in charge of the Headache and Craniofacial Pain Clinical Unit and the Director of the Migraine Adaptive Brain Center at the Vall d’Hebron University Hospital in Barcelona, Spain; and the Group Leader and Principal Investigator of the Headache & Pain Research Laboratory at the Vall d’Hebron Institute of Research (VHIR), which belongs to the Universitat Autonoma of Barcelona (UAB).
She is a member of the Board of Trustees of the International Headache Society, the Council of the European Headache Federation and the Scientific Advisory Board of the Fundación Lilly Spain and the Migraine Research Foundation.
Dr. Pozo-Rosich’s research focuses on better understanding the pathophysiology of migraine with the goal of improving the quality of life of patients and help reduce the stigma of migraine.
She is the founder and developer of www.midolordecabeza.org .
Katherine Price Snedaker – Keynote
LCSW, Executive Director and Founder of PINK Concussions
Katherine Price Snedaker, LCSW, is the Executive Director and Founder of PINK Concussions, a non-profit, for female brain injury from sport, domestic violence/assault, accidents or military service. Based in America, PINK Concussions’ international mission is to drive change and innovation to develop sex/gender-appropriate, evidence-based research approaches on identification, management and support of women and girls with brain injuries.
Snedaker is an international speaker, brain injury professional, published researcher, and parent of a child with a brain injury. She has been featured in Scientific American, Marie Claire, US News & World Report, Washington Post, HEALTH, STAT, AP: the Big Story, Neurology Advisor, Good Morning America, NBC, FOX, ESP-Outside the lines, and Aljazeera.
Signe Ratso – Keynote
Deputy Director-General for Research and Innovation, DG RTD
Signe Ratso is Deputy Director-General and a member of the Management Board of the Directorate General for Research and Innovation of the European Commission. She is the Chief negotiator for Horizon Europe Association. She is also responsible for Open Innovation and for citizens’ engagement in research and innovation policy and for overall coordination on international cooperation.
Signe Ratso joined DG Research and Innovation as Deputy Director General on 1 March 2018. In this function her particular areas of responsibility included International Cooperation in Research and Innovation as well as R&I in Industrial Technologies and in the area of Transport until 1 June 2019.
Before joining DG RTD she worked in different senior management positions in DG TRADE since 2006.
Before joining the Commission Signe Ratso worked as Deputy Secretary General (from 1994 to 2005) at the Ministry of Economic Affairs and Communications of the Republic of Estonia. In this position she was responsible for all EU-related issues in the following policy areas: trade and industrial policy, energy, transport, telecommunications, information society, internal market affairs. During Estonia’s accession negotiations she was responsible for negotiating 6 economic chapters.
She has two University degrees. In 1983 she graduated from Tartu University in Estonia as an English philologist, in 1993 in International Trade and International Economics.
Dr David Roomes – Panel 4
Chief Medical Officer
David is responsible for leading the Global Health, Safety, Wellbeing and Environment function at Rolls-Royce. Previous roles were with Rio Tinto (mining), GlaxoSmithKline (pharmaceuticals) and the NHS. As part of the Rolls-Royce People Leadership Team, David is currently focussed on embedding workforce wellbeing as an enabler to enhance engagement, productivity and performance.
David is a practising physician and is a Fellow of the Royal College of Physicians, a Fellow of the Faculty of Occupational Medicine and a Fellow of the American College of Occupational and Environmental Medicine. His special interests are the occupational impact of chronic pain disorders and workplace mental health and wellbeing.
Elena Ruiz de la Torre – Panel 4
EMHA Executive Director
Mrs Ruiz de la Torre has been Executive Director of the European Migraine & Headache Alliance (EMHA) since 2018. Since its inception in 2006, the EMHA has grown to include 35 patient groups throughout Europe, and Mrs Ruiz de la Torre continues to work in partnership with the European Headache Federation (EHF) to provide a united voice on the rights and needs of 138 million people living with headache disorders in the region.
She is Honorary President of the Spanish Association of Migraine and Headache (AEMICE) and a Member of the Steering Committees of the International Headache Society Global Headache Advocacy Coalition, the European Patients Advisory Council, the International Migraine Council, and the Multidisciplinary Migraine Expert Group. She is also Member of the European Federation of Neurological Associations and of the EHF School of Advanced Studies. Her involvement with the EHF extended to her being a Member of the EHF Congress Faculty for the Athens 2019 meeting.
As an active patient advocate, Mrs Ruiz de la Torre has co-authored several publications and been involved in several key projects. She participated as Co-Chair for the “My Migraine Voice Survey”, a global cross-sectional study that surveyed over 11,000 migraine patients to help understand the full burden and impact of migraine in Europe. She was also a Steering Committee Member for “Migraine Matters”, a tool built by the Patient Advocate Foundation to provide patients with actionable, tailored information and resources on migraine-related topics.
Prof. Londa Schiebinger – Keynote
John L. Hinds Professor of History of Science at Stanford University
Londa Schiebinger is the John L. Hinds Professor of History of Science at Stanford University, and Director of EU/US Gendered Innovations in Science, Health & Medicine, Engineering, and Environment. She is a leading international expert on gender in science and technology and has addressed the United Nations on that topic. Schiebinger received her Ph.D. from Harvard University, is an elected member of the American Academy of Arts and Sciences, and the recipient of numerous prizes and awards, including the prestigious Alexander von Humboldt Research Prize and Guggenheim Fellowship.
Gendered Innovations harnesses the creative power of sex, gender, and intersectional analysis to enhance excellence and reproducibility in science and technology. See AI can be Sexist and Racist—It’s Time to Make it Fair Nature (2018); Sex and Gender Analysis Improves Science and Engineering Nature (2019).
Priyal Sheth, MSc – Panel 6
Neuroscientist / VP of Business Development nQ Medical
Priyal is a neuroscientist by training from Columbia University, and works as a neurotech / digital health business development consultant. A few of his neuroscience / digital health clients including MetaCell, SparkNeuro, nQ Medical, Broadwing, and Q1.6. Currently he’s working with:
- nQ Medical is a new computational digital biomarker company measuring fine motor function & cognition. The technology uses personal devices to assess neurological health through 24/7 passive data collection with no proprietary device required and no tasks
- Q1.6 develops agnostic communications products built upon Stanford research that has found ‘your Un-conscious made conscious, in 1.6 seconds’ in order to improve patient engagement for biopharma and medical device companies.
A little more about Priyal, he’s hosted webinars on Neuroscience Investing & Modeling the Brain.
Eliot Sorel, MD – Keynote
Co-chairs the Metrics Group of the Healthy Brains Global (HBG) and is a cofounder of the Africa Global Mental Health Institute.
Eliot SOREL MD is an innovative global health leader, educator, health systems performance expert, and a practicing physician. He co -chairs the Metrics Group of the Healthy Brains Global (HBG) and is a cofounder of the Africa Global Mental Health Institute. Doctor Sorel has served as a subject matter expert on World Health Organization (WHO), U.S. National Institute of Health,(NIH), Fogarty International Center, U.S. National Institute of Mental Health, (NIMH), World Bank Group (WBG), the Inter -American Development Bank (IADB), and the Organization for Economic Cooperation & Development (OECD) projects.
- At the George Washington University, in Washington, DC, Dr. Sorel is the lead physician teaching Global Mental Health in the Milken Institute School of Public Health. He is Clinical Professor of Global Health, Health Policy & Management and of Psychiatry & Behavioral Sciences.
- Dr. Sorel works collaboratively with primary care and public health colleagues. The innovative, TOTAL Health model, a primary care, mental health & public health integrated/collaborative template was initiated by Dr. Sorel as a means of enhancing quality, access, and sustainability of care. In June 2018, he was the President of the 1st International Perinatal TOTAL Health Congress. Dr. Sorel is the lead author of “Healthcare, Inclusive of Mental Healthcare, Is a Human Right”. It is now American Psychiatric Association policy since December, 2017. He co-chaired the scientific committee of the Social Determinants of Health/Mental Health & Access to Care World Congress, October 2019, www.wasp2019bucharest.org.
- He initiated and led the clinical public health research project on Depression & Comorbidity in Primary Care in China, India, Iran, Romania published in the International Medical Journal and shared at the World Bank Group/WHO Innovators’ Fair in Washington, DC in April 2016.
- Dr. Sorel coauthored the APA position statement on Integrated Care of 2016 and the WPA Bucharest Statement on Integrated Care & Collaborative Care of 2015. 21st Century Global Mental Health is the one of seven books published by Dr. Sorel. His most recent publications are, Covid-19: A National and Global Social Contracts Stress Test (in press), and The Social Brain: Wired to Connect and Belong, in http://www.worldsocpsychiatry.org. He was a subject matter expert to the OECD’s Making Mental Health Count project accessible at www.oecd.org .
- Amici Curiae Brief of Public Health Experts, the American Public Health Association, and the American Academy of Nursing, California, et al., v Texas, No. 19-840 and No. 19-1019 (United States Supreme Court, May 2020), co-signatory.
- Amici Curiae Brief of Public Health Deans, Chairs, and Faculty, and the American Public Health Association, King, et al., v. Burwell, No. 14-114 (United States Supreme Court, January 2015), co-signatory.
- The George Washington University’s Milken Institute School of Public Health honored Dr. Sorel as a Pioneer and Leader in Public Health in December 2019. He received the Mental Health Champion Award at the Universal Health and Mental Health for All Conference in Malta, E.U., in December, 2018. Carol Davila Medical University and the Politehnica University of Bucharest, Romania, honored Dr. Sorel with Doctor Honoris Causa in October 2009 and in June 2014, respectively. The President of Romania decorated Dr. Sorel with the Star of Romania Order of Commander in January 2004.
Sonali Quantius, Ph.D – Panel 6
Founder of mindhealth, ETH Zurich
Dr. Sonali Quantius received her PhD degree in Biochemistry from the University of Zürich.
Following a postdoctoral stint in proteomics at ETH, Zürich, she held positions of increasing responsibility in global pharmaceutical companies such as Eli Lilly in Singapore and USA, AstraZeneca in Sweden, and most recently as Director of Computational Biology, Human Genetics in GlaxoSmithKline, U.K to identify novel targets and biomarkers.
Recently, she left the Pharmaceutical industry to follow her passion and interest in increasing medication safety for underrepresented communities by starting a digital health company that supports the early detection of depression and response to antidepressants in women using digital phenotyping and machine learning along with easy and secure access to therapies.
She works with Prof. Dr. Ernst Hafen at ETH to ensure that citizens have control over their personal data with the highest standards of data safety and data protection as part of this initiative. In her free time, Sonali loves running and spending time with her family & friends.
Cristina Tassorelli – Panel 4
MD, PhD, Full Professor of Neurology,Dept of Brain and Behavioral Sciences, University of Pavia IRCCS C. Mondino Foundation, Pavia (I)
Director of the Headache Science Centre and the Neurorehabilitative Unit at the IRCCS C. Mondino Foundation, Chair of Neurology and Director of the Neurology Residency Program at the University of Pavia. President-elect of the International headache Society
Dr Tassorelli received a medical degree summa cum laude from the University of Pavia. She was an intern at the C. Mondino National Neurological Institute as part her training as an MD, completed her training in Neurology at the University of Pavia and then obtained a PhD Degree in Human Psychobiology at the University of Modena (Italy). She spent a 2-year Post-Doctoral Fellowship at the Dept. of Neuroscience of the University of Rochester (NY).
She has served as a director in the Board of the International Headache Society and as Chair of the Committee for the Guidelines of Clinical Trials. She was a founding member and vice-President of the European Headache Alliance.
She is presently Chief Section Editor of Frontiers in Neurology, section Headache Medicine and Facial Pain.
She has been the coordinator and/or a partner in competitive grants funded by the EU, the Italian Ministry of Health and the Italian Ministry of University.
Dr. Tassorelli has authored more than 280 peer-reviewed publications and coauthored several books and book chapters.
Kaveeta Parikh Vasisht – Panel 3
Associate Commissioner for Women’s Health at the U.S. Food and Drug Administration (FDA)
Dr. Kaveeta Vasisht is Associate Commissioner and Director of the Office of Women’s Health (OWH) in the Office of the Commissioner of the U.S. Food and Drug Administration (FDA).
Under her leadership, OWH works to protect and advance the health of women through scientific programs, policy development, research, education, stakeholder collaboration, and outreach that incorporates an understanding of sex and gender differences to facilitate FDA regulatory decision making.
Dr. Vasisht is board-certified in both internal medicine and adult endocrinology and holds a Doctor of Pharmacy degree. She completed her internal medicine internship and residency as well as fellowship training at the University of Chicago Hospitals, where she also served on the faculty. She obtained her medical degree from the University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School.
George Vradenburg – Keynote
World Dementia Council Member, Co-Convener of CEOi
Chairman and Co-Founder USAgainstAlzheimer’s
George Vradenburg is the Chairman of UsAgainstAlzheimer’s (UsA2), a disruptive and catalytic force he co-founded in 2010 to accelerate action to stop Alzheimer’s disease. He is a member and trustee of the World Dementia Council and a Distinguished Fellow with the World Economic Forum. He chairs the Global Alzheimer’s Platform (GAP), the only patient-led Alzheimer’s clinical trial network, and he and UsA2 serve as the convener of the Global CEO Initiative on Alzheimer’s (CEOi).
Alexandra Kautzky-Willer – Panel 5
Interim head of the Department of Internal Medicine III as well as Head of the Division of Endocrinology and Metabolism of the General Hospital and Medical University of Vienna
Head of the Gender Medicine Unit and the University Course Gender Medicine of the Medical University of Vienna.
President of the Austrian Society of Gender-Specific Medicine.
President of the International Society of Gender Medicine. Professor of Gender Medicine.
Carolee Lee – Keynote
Founder and CEO, AccessCircles, WHAM!
AccessCircles was founded in June of 2008 by Carolee Friedlander, the former CEO and founder of Carolee Designs, one of the world’s leading accessories brands. Carolee’s vision is to create a by invitation network to enrich the health and wellness, financial expertise and life balance of women through informative gatherings, transformative knowledge, unique experiences and access to leading authorities and alliance partners in the fields of health and wellness, financial expertise and life balance.
In July 2018, WHAM! was launched by Carolee Lee as an initiative of AccessCircles (a 501c3) to focus on increasing awareness of women’s health issues, investing in women’s health research and implementing strategies that will improve the inequities and bias in research while accelerating scientific discovery. The Connors Center at Brigham/Harvard is WHAM!’s Lead Scientific Partner.
As founder and CEO of Carolee Designs, Carolee led her organization through all business life cycles, from early stages to a highly respected, recognized brand. During that time, Carolee was considered the trendsetter in both design and marketing of fashion accessories worldwide, creating collections with distribution in over 700 premier retail stores internationally. This quintessential entrepreneur had grown businesses through global expansion, product diversification and a keen understanding of the changing needs of women today.
In 2001, Carolee negotiated the sale of Carolee Designs to Retail Brand Alliance, a privately held retail company with sales of $1.5 billion. She remained with the company until 2005.
Throughout her career, Carolee has embraced mentoring and leadership roles in many diverse business organizations and is active in numerous civic, philanthropic and educational organizations. Some of those include:
The Women’s Leadership Board at The John F. Kennedy School of Government; Fashion Institute of Technology (FIT); Council of Fashion Designers of America (CFDA); Women’s World Bank; The Society for Women’s Health Research; The Museum of Arts and Design in NY.
She is a past president of the Committee of 200, the organization of preeminent businesswomen and also served as the Chair of its Foundation Board. Carolee serves as a director on the board of DSW, Inc., a major footwear retailer and The Breast Cancer Research Foundation, where she is a founding board member and has served since 1996..
Carolee has been recognized with numerous awards and recognitions for her professional and philanthropic achievements.